Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
11/20/2003 | US20030216338 Bacteriophage having multiple host range |
11/20/2003 | US20030216285 Selected from the group consisting of alloxazines and photosensitizers |
11/20/2003 | US20030215942 Preparing stem cell libraries for therapeutic use in event of exposure to nuclear radiation |
11/20/2003 | US20030215921 Vascular endothelial growth factor-2 |
11/20/2003 | US20030215898 Methods for using 22045, a human cyclic nucleotide phosphodiesterase |
11/20/2003 | US20030215831 Renal regulatory elements and methods of use thereof |
11/20/2003 | US20030215808 Selecting, screening or characterizing a compound by contacting it with lymphocytes and determing it ability to regulate activity |
11/20/2003 | US20030215785 Solution containing platelet activation inhibitors for pathogen reducing and storing blood platelets |
11/20/2003 | US20030215506 Methods and compositions for enhancement of creatine transport |
11/20/2003 | US20030215480 For use against plant parasitic nematodes; waste treatment |
11/20/2003 | US20030215467 Isolated from resected and washed human gastrointestinal tract; for oral administration; probiotics |
11/20/2003 | US20030215461 Immunogenic composition comprising adenyl cyclase-hemolysin protein, or portion thereof, strain of Bordetella chosen from B.pertussis, B.parapertussis or B.bronchiseptica, bacterial extract containing expression product of bordetella vrg genes |
11/20/2003 | US20030215460 Methods and compositions for inducing an immune response |
11/20/2003 | US20030215443 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
11/20/2003 | US20030215429 Lyophilised or sonicated Lactobacillus bacteria, grampositivie bacteria, gramnegative bacteria; antitumor agents, therapeutic treatment of autoimmune diseases, gastrointestinal disorders, nervodegenerative diseases |
11/20/2003 | CA2487280A1 System and method for forming a substantially non-ablative cardiac conduction block |
11/20/2003 | CA2487254A1 System and method for treating cardiac arrhythmias with fibroblast cells |
11/20/2003 | CA2485655A1 Recombinant fowlpox virus |
11/20/2003 | CA2485567A1 Treatments with autologous fibroblast |
11/20/2003 | CA2484607A1 Methods and compositions for inducing an immune response |
11/20/2003 | CA2484398A1 Method for reducing pain using oncolytic viruses |
11/20/2003 | CA2484144A1 Eif-5a nucleic acids for inhibiting apoptosis |
11/20/2003 | CA2483046A1 Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer |
11/20/2003 | CA2462203A1 Methods and products for enhancing immune responses using imidazoquinoline compounds |
11/19/2003 | EP1362596A2 Inhibitor of stem cell proliferation and uses thereof |
11/19/2003 | EP1362104A2 T cell receptor variants expressed in mesenchymal cells and uses thereof |
11/19/2003 | EP1362096A2 Pigmentary epithelium cell of the eye, the production thereof and the use of the same for treating diseases of the eye or of the central nervous system |
11/19/2003 | EP1362095A2 Post-partum mammalian placenta, its use and placental stem cells therefrom |
11/19/2003 | EP1361896A2 Localized myocardial injection method for treating ischemic myocardium |
11/19/2003 | EP1361888A2 Method of treating neurologcial diseases |
11/19/2003 | EP1361884A2 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus |
11/19/2003 | EP1214080B1 Glucosamine and hyperimmune egg for reducing inflammation |
11/19/2003 | EP1096942B1 Use of a medicine containing a quantity of tyrothricine for the treatment of viral infections |
11/19/2003 | EP0815144B1 Therapeutic uses of glucan |
11/19/2003 | CN1457259A Method for preventing and curing diseases of immune system and remedy for carrying out said method |
11/19/2003 | CN1456341A Lung clearing oral liquid preparation for treating viral pneumonia in Children and preparing method thereof |
11/19/2003 | CN1456340A External applied pedicure ointment |
11/19/2003 | CN1456338A Medicine for treating diabets mellitus |
11/19/2003 | CN1456313A Tiegudan for ischemic necrosis of fernoral head |
11/19/2003 | CN1456277A Medicine for treating cirrhosis |
11/19/2003 | CN1456227A Medicine for curing hepatitis B |
11/19/2003 | CN1456217A Medicine for curing choleithiasis and preparing method thereof |
11/19/2003 | CN1456203A Chinese medicine preparation against cold |
11/19/2003 | CN1456198A Angong hemostatics |
11/19/2003 | CN1456178A External applied medicine for curing burn and preparing method thereof |
11/19/2003 | CN1456177A Method and apparatus for producing fibroin powder |
11/19/2003 | CN1456176A Pearl nano-materials preparing method |
11/19/2003 | CN1456175A Pelma musk contraceptive paste and preparing method thereof |
11/19/2003 | CN1456174A Anti-anoxia anti-fatigue biological preparation for improving human |
11/19/2003 | CN1456173A High-efficiency fast styptic |
11/19/2003 | CN1456170A External applied medicine composition containing vitamin š�* |
11/19/2003 | CN1456107A Healthy beverage |
11/19/2003 | CN1128220C Process for separating worm kinase |
11/19/2003 | CN1127979C Medicine 'Buyuan Jianmei Wan' |
11/19/2003 | CN1127978C Hyperosteogeny treating medicine |
11/19/2003 | CN1127974C Chinese medicinal preparation for fracture |
11/19/2003 | CN1127973C Medicine for hepatitis |
11/19/2003 | CN1127972C Medicine for cancers and its preparation |
11/19/2003 | CN1127971C Medicine for senile dementia |
11/19/2003 | CN1127970C Ointment for treating burn and its preparing process |
11/19/2003 | CN1127969C Medicinal spirit for hyperosteogeny |
11/19/2003 | CN1127967C Capsules for hypertension and their preparation |
11/19/2003 | CN1127964C Chinese medicine for treating dermatopathy (leukoderma and psoriasis) |
11/19/2003 | CN1127963C Oral liquid of chitosan and lucid ganoderma and its preparing process |
11/19/2003 | CN1127962C Capsule for curing hydrocephalus and its producing method |
11/19/2003 | CN1127948C Microencapsulated bovine adrenal medulla chromaffin cell-drug for alleviating pain |
11/18/2003 | US6649590 Heating; removal precipitates; recovering; ultrafiltration; ion exchange resin |
11/18/2003 | US6649391 Isolated polynucleotide encoding a polypeptide of given sequence; dephosphorylates MAP(mitogen activated protein)-kinase; used for modulating cell proliferation, differentiation and survival |
11/18/2003 | US6649386 Stability; for reconstitution with water; antihemophilic factor; blood factor IX |
11/18/2003 | US6649375 Adenoviral vectors for enhanced gene expression |
11/18/2003 | US6649373 Use of trans-activation and CIS-activation to modulate the persistence of expression of a transgene |
11/18/2003 | US6649339 Screening for the presence of a parvovirus genome equivalent using nucleic acid amplification; purification |
11/18/2003 | US6649194 Topical analgesics and methods of use |
11/18/2003 | US6649185 For the treatment of cancer; particularly, the formulation can be used to treat haematological malignancies |
11/18/2003 | US6649160 Sertoli cells as transplantation facilitator for cell transplantation |
11/18/2003 | US6649157 Treating a Ras-mediated cell proliferative disorder in a mammal, by administering a modified adenovirus, modified HSV, modified vaccinia virus or modified parapoxvirus orf virus resulting in lysis of the proliferating cells. |
11/15/2003 | CA2386550A1 Method and system for modulation and modification of microbial cell characteristics and production of modified microbial materials |
11/13/2003 | WO2003093740A1 Container for transporting biological material |
11/13/2003 | WO2003093512A1 Methods and compositions for the modification of nucleic acids |
11/13/2003 | WO2003093485A2 Optimization of transgene expression in mammalian cells |
11/13/2003 | WO2003093463A1 Improved viral purification methods |
11/13/2003 | WO2003093462A2 Immobilisation and stabilisation of virus |
11/13/2003 | WO2003093458A1 Isolation of target cells, capillaries and microorgans |
11/13/2003 | WO2003093455A2 Adenovirus vectors for immunotherapy |
11/13/2003 | WO2003093431A2 Ablated slam-dependent entry |
11/13/2003 | WO2003093418A2 Keratinocytes expressing exogenous angiogenic growth factors |
11/13/2003 | WO2003092894A2 Method and apparatus for isolating platelets from blood |
11/13/2003 | WO2003092745A1 Methods for sterilizing tissues using cryopreservatives |
11/13/2003 | WO2003092738A1 Drug- or gene-carrier composition having lowered hemagglutinin activity |
11/13/2003 | WO2003092717A1 Cancer immunotherapy |
11/13/2003 | WO2003092715A2 Proteins involved in the regulation of energy homeostasis |
11/13/2003 | WO2003092711A1 Method of enhancing biological activity of plant extracts |
11/13/2003 | WO2003092708A1 Antitumor agents with the use of hsv |
11/13/2003 | WO2003092657A1 Microparticles bearing cells and active substances |
11/13/2003 | WO2003092653A1 Apparatus and method for delivery of bacteria to the vaginal tract |
11/13/2003 | WO2003092615A2 Use of anti-cd1 antibodies for the modulation of immune responses |
11/13/2003 | WO2003092612A2 VECTORS HAVING BOTH ISOFORMS OF β-HEXOSAMINIDASE |
11/13/2003 | WO2003092604A2 Vascularization enhanced graft constructs |
11/13/2003 | WO2003092579A2 Compositions and methods for treating cancer with an oncolytic viral agent |
11/13/2003 | WO2003092474A2 Vascularization enhanced graft constructs |